E-Pharma is an highly specialized pharmaceutical company dealing with solid oral delivery forms: effervescent, orally disintegrating, sublingual, chewable as well as soluble ones. With our proprietary technologies we study, develop and manufacture high quality standard profile products in the pharmaceutical, food supplements and medical device fields. Our primary business model is to license out our dossiers to our customers worldwide and to manufacture the products under our customer's brand name in our EU-GMP certified plant in full service conditions. We also proactively collaborate on contract development and contract manufacturing projects. Our mission is to bring innovation to our customers wishing to generate added value to their portfolio and enhance their products life cycle with our technologies. E-Pharma, your reference in the oral delivery forms.
EBInnov® research laboratory is organized around four areas of expertise:-
1. Innovation- Creation of active ingredients or excipient.
2. Production- Optimization of the production of natural or synthetic substances.
3. Formulation-Design and validation of methods for the formulation and sensory evaluation of pharmaceutical products.
4. Prevention- Evaluation of industrial and environmental risks, product protection
The EBInnov® lab includes all the scientific activities of the faculty and students of the EBI. From research to entrepreneurship, teachers carry out work connected to the problems of our application areas.
EBInnov has facilities dedicated to each of its R & D activities organized in technological platforms and laboratories. Each facility is equipped with all the hardware for performing the techniques necessary for research and applications. They can be used for pedagogical manipulations, but also to development projects or research, or be used by the incubated companies or companies with a need for technology transfer.
right Partner in Brazil
Since 2002 EcoTag represents manufacturers/exporters promoting our premium partner companies to a powerful range of buyers.
We deal with API and Finished dosage for Pharmaceutical, Feed and Food industries.
Our team is experienced and committed to create solutions leading to successful and pro?table long-term relationships.
The EDQM is a European body which equips Authorities and
manufacturers worldwide with the European Pharmacopoeia, its reference
standards and Certificates of Suitability to the Monographs of the European
Pharmacopoeia (CEPs). The European Pharmacopoeia is THE PHARMACOPOEIA FOR
EUROPE and is mandatory in 38 European countries. It outlines the quality
requirements which must be met in order to get medicines approved in Europe. CEPs
are certificates directly used in the quality section of Marketing
Authorization Dossiers and they are officially recognized by more than 70
countries worldwide. The European Pharmacopoeia and CEPs are manufacturers'
preferred gateway to access the European Market and beyond.
The European Pharmacopoeia contains more than 3000 legally binding quality standards for medicines on the European market. They cover all kinds of ingredients used in medicines for human and veterinary use. They are applicable at the same time in all countries. Free services include access to the KNOWLEDGE database and access to the online Helpdesk. Share also your expertise by reading and commenting draft European texts in Pharmeuropa.
Egis Pharmaceuticals PLC a leading generic pharmaceutical company operating principally in Central and Eastern Europe is active in full pharmaceutical value chain from R&D through production of APIs and drug products to sales and marketing in more than 60 countries.
Egis has extensive experience in development of value-added generic molecules, efficient manufacturing processes, robust analytical methods for determination of impurities, comprehensive knowledge of organic chemical reactions and operations and strong IP support.
By recent investments development capabilities were significantly increased especially with the construction of the API R&D Centre including a dedicated lab for HPAPI development.
is the leading producer of offset-printed cardboard packaging in Slovenia and has in recent years been steadily increasing its worldwide market-share. With over 50 years history in packaging production it has
unrivalled experience in the industry. Its
continuous investment in technology and product development enables EGP to
provide premium packaging and services
required by sophisticated clientele. EGP specialises
in folding cardboard boxes and the primary focus is on producing packaging for the
pharmaceutical, personal care and cosmetics industries. Through innovation and
technological excellence, EGP produces printed cardboard packaging to increase
the competitiveness of its customers.
Ehfield works on Pharmaceuticals and Chemicals supply for above ten years . We have developed extensive connections with the global markets and accumulated good knowledge about market access to the international business. Our products are made in GMP ,ISO,Euro GMP, cGMP ,FDA ……approved facilities.
Innovation is the another main engine of our activities. We keep investing in research and development. Part research is oriented to the development of even more cost-reducing solutions.
We dedicate to develop a team spirit and hope our staff enjoy working together.
Ehfield sincerely believes that our clients' welfare is just our welfare ,our clients' developments and benefits are the prerequisite of our developments and benefits.
EIPICO is the leading Egyptian pharmaceutical company concernined with developing, manufacturing and marketing wide range of pharmaceutical products. EIPICO produces more than 300 products that cover most therapeutic groups including traditional and non-traditional dosage forms. EIPICO exports to 65 countries - Europe, Latin America, Africa, Asia and Middle East. EIPICO made license agreements with a group of international pharmaceutical companies. EIPICO factories inspected regularly from the countries that are dealing with and have passed highly successful in various types of quality inspection in production, laboratories and environment such as MAHRA-UK, NMA-Romania, MCC-RSA, CIS, WHO Prequalification, PIC S and GCC States.
EirGen Pharma is part of OPKO Health plc, founded by Dr Philip Frost and listed on the Nasdaq. We're a world-leader in the development, registration, pharmaceutical contract manufacturing and supply of high-potency pharmaceutical products to global markets. Based in Waterford, Ireland, we partner with top pharmaceutical companies, using state-of-the-art high containment facilities to develop and supply life-saving medicines all over the world. Our commercial OSD facility is FDA, EMA & PMDA approved and we export products to over 50 countries. Our $40M state-of-the-art injectable line for fill and finish opportunities is under qualification and we welcome business discussions at CPhI 2018, visit us at stand 14.0B61 or contact [email protected] to set up a meeting.
Element Chemilink Pvt. Ltd. is one of India's fastest growing pharmaceutical companies uniquely positioned to become the next leader across Emerging Markets. Our corporate office and manufacturing facility located at Ankleshwar, Gujrat, India. Element Chemilink, India has grown ever since to now specialize in the manufacturing of prime API drugs, their intermediates, advance intermediates, Phase Transfer Catalysts, Pharmaceutical and agrochemical impurities, Reference standards, specialty chemicals for bulk drugs and fine chemicals. Our Products business comprises manufacture and sales of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets. Our values help define who we are and the kind of company we aim to be. Ethics, Compliance, Quality, Respect and Entrepreneurship are at the heart of everything we do. Our purpose is to keep improving the quality of life by offering value added Intermediate products those are technologically innovative, cost-effective and of superior quality, surpassing expectations of customers across the globe. We are manufacturer of advance intermediates of Tramadol Hydrochloride and Sertraline hydrochloride.
elm-plastic GmbH is a German family-owned company that was founded in 1969. On a production area of 4500sqm we are producing high quality plastic parts at a technically superior standard with a staff of about 120 employees in three shifts. Our product range mainly consists of pharmaceutical primary packaging products and dosing instruments for human and veterinary medicine. Our satisfied clientele includes well-known international pharmacists and bottlers. Our products are the outcome of a long-standing cooperation between pharmacists, bottlers, users and our development department.
ELPEN is a privately owned, Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has 900 employees and an annual turnover of €200 million. It ranks as 1st among Greek companies and 7th overall among 400 companies operating in Greece. At the moment, its products are commercialized in 39 countries and all of them are manufactured under the strict EU guidelines. ELPEN has a production facility of 10.000m2 and its research facility (The Experimental – Research Center ELPEN) is the first and largest laboratory for experimental biomedical research and training center in Greece that originates from the private sector and it is ranked within the top 5 in Europe. If you are interested in learning more about the rich pipeline of products that ELPEN is working on, please contact our International Business Development team.
ELS Solutions - www.elssolutions.com.br - is a strategic advisory company for the pharmaceutical, health and wellness industry. Its solutions integrate a wide range of medical specialties, covering innovative medicines, medical devices, food supplements and cosmetics. Specialized in innovation, whether in the field of new business or R&D, ELS Solutions has the primary objective of contributing strongly to the growth of its partners in the pharmaceutical, health and wellness industries. Its services enable new business in a more agile way, efficient registration of new products and the anticipation of launches, including the phases of identification, strategic planning, development, licensing, launching and commercialization of new products, in a faster manner. Having an ISO 13485: 2016 certification for medical devices, ELS Solutions is duly certified as European Union Authorized Representative. With offices in Sao Paulo, Buenos Aires and Lisbon, ELS Solutions leads internationalization processes for Europe and Latin America, converting its team expertise into its clients competitiveness. @ [email protected]
It all began in 1996. The setting of our itinerary, the journey, the milestones, fellow travellers, and everything else along the way.
Established then as a formulations unit, Elysium commenced its journey a good two years later, in 1998, crossing many important milestones along the way. The most important being our success in establishing ourselves as the most preferred contract manufacturer for the most reputed multinationals and some of India's leading brands of pharmaceutical products.
Elysium's repute in the industry is in no small measure due to our stringent manufacturing processes that comply with even the most stringent standards. Be it current Good Manufacturing Practices, Good Laboratory Practices, regulatory requirements or international guidelines for the development, manufacture, release and distribution of products across all formats.
EMA Pharmaceuticals is a leading European manufacturer of closures for pharmaceutical containers. For almost a century, EMA Pharmaceuticals has been a partner of confidence for the pharmaceutical industry, serving over 170 production sites of parenteral drugs worldwide with high-end sealing solutions. Its production facility, located near Orl
EMBELIA designs and distributes standard or customized primary packaging solutions for pharmaceutical industries, in France and abroad. EMBELIA offers full-service (bottles, jars, closures and decoration) and multi- material solutions (moulded glass, clean and sterile tube glass vials, injection moulding caps, aluminium bottles and caps).
Emcure Pharmaceuticals Limited researches, develops, manufactures, and markets pharmaceutical products. The company provides therapeutic products in the fields of cardiology, nephrology, blood related, anti-infective, pain and analgesics, gynecology, HIV, vitamins, minerals, nutrients, diabetes, cardio/anti hypertension, antibiotics, hematologic/iron preparations, and oncology. It also offers solid orals, active pharmaceutical ingredients, injectables, soft-gelatin capsules, biosimilars, vaccines and mAbs, and generics; and tablets, syrups, eye drops, solutions, ointments, pessaries and applicators, transdermal patches, suppositories, creams, liquids, gels, and oral suspensions. It serves individuals, hospitals, wholesalers, and pharmacists in India and internationally. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India with manufacturing facilities in India and the United States
Emergent BioSolutions (acquirer of Cangene bioPharma) provides contract manufacturing services for both bulk drug substances and finished drug products. Emergent's state-of-the-art single-use BDS facility enables turnkey upstream and downstream support for microbial, mammalian and viral cell lines. Emergent's Fill/Finish service offering includes vials and syringes, for both liquid and lyophilized products (including lyo cycle development). Emergent's manufacturing facilities (located in Baltimore, MD) currently produce 20 commercial products and supported over 200 clinical drug products. For more information, visit www.emergentcontractmanufacturing.com
Pharmaceutical Industries Private Limited is engaged in manufacturing and
marketing of pharmaceutical, nutraceutical and OTC formulations since 1989. Emil Group
manufacturing facilities are accredited with WHO - GMP certification, NAFDAC
Nigeria, FDA Philippines, FDA Ghana, DPML Ivory Coast, FDA Haiti & NDA
In addition our products are registered with ISP Chile, Uruguay, Suriname, Venezuela, Costarica, Jordan, CDDA Sri Lanka, FDA Myanmar, DRU Bostwana, FDA Vietnam, Georgia, Azerbaijan, Hongkong, South Africa (nutraceuticals & OTC) etc to name a few.
Tablets, Capsules & Powder dosage forms are manufactured at our facilities. Over 200 formulations across 20 therapeutic categories are manufactured at our facilities.
Emil Group does contract manufacturing for large MNC's and – Pfizer Ltd, Abbott Ltd., Merck Ltd., USV Ltd., Wockhardt Ltd , Glenmark Ltd, Meyer Organics Ltd., etc to name a few.
Emil Group exports products to over 20 countries in South East Asia, Africa, Latin America & CIS.
In 1995 Emphasys shareholders started their companies in the fields of precision injection-molding and sales of quality devices for the pharmaceutical and cosmetic industries. In 2004 a venture company was created with the objective of using mutual know-how for development of innovative delivery systems. The experience of the R&D team allowed the company to generate new patents and develop cost-effective delivery systems, opening new market opportunities for the medical and cosmetics fields. With the growth of the company, in 2008 a new production facility was acquired to enable expansion and compliance with ANVISA, EMEA and FDA.
EMS is the 1st pharmaceutical industry in Brazil and 2nd largest in Latin America. EMS is a key player in therapeutic areas among OTC, generics, brand and hospital drugs with a wide portfolio including:- solids, orals and syrups. EMS is leading the pharmaceutical market, exporting to over than 40 countries.
Enable Innovations Srl has been recently founded with the aim to to study and develop new and innovative products in the field of Pharma and Medical Devices so as to improve the state of the art both for the patients and for the specialists. The activity of Enable Innovations is focused on the sterile liquid products and in particular on the preparation and filling in aseptic conditions of solutions in single dose vials (in monodose strip – set of 5 units) and multidose preservative free.
Enaltec was established in 2006 with the specific objective
to develop and produce niche and technology driven API at competitive prices through
its WHO GMP and US FDA approved sites and supply across the world. Enaltec has further strengthen its foothold in generic formulation
development through its R&D site Enaltec Pharma Research, having capacity to
develop wide range of dosage forms ranging from Solid oral, liquid oral, Derma,
Injectable, Potent molecule (Oncology and Hormones), Undertake cGMP analytical method
validation and registration ICH stability studies at Enaltec Formulation Labs.
ENALTEC= (API R&D + API Manufacturing) + (Formulation R&D [FFS/Turnkey])
Enantia is a leader in cocrystallization technologies and chiral chemistry. Enantia develops chemical and solid state technologies for the fine chemicals and pharmaceutical sectors. The company can contribute all the way from initial research in medicinal chemistry or route scouting to any phase of process R&D. Enantia's unique approach allows for creative and innovative solutions which make possible the most challenging projects.
Enbridge PharmTech Co., Ltd. is an innovative company integrated with R&D, manufacturing, marketing and distribution of intermediates and fine chemicals, mainly used to pharmaceutical, pesticide, cosmetics, health care products and electronic chemicals. Our core services also include Custom Synthesis and Contract Manufacturing Services.
Founded in the early '80s Encaplast Spa has preserved and pursued the same values of the past: quality, reliability and innovation. The company currently offers packaging solutions for medium and large enterprises in the medical and pharmaceutical sector, as well as small customized lots for specific requirements handled by the internal technical office. Now Encaplast Spa is a joint-stock company and, while maintaining its roots in Mirandola's medical district (Modena, Italy), it aims to increasingly strengthen its position in the international market.
Cosa Partners Corporation is a supplier focused on packaging equipment for the food, cosmetic and pharmaceutical industry. Cosa builds solid partnerships with packaging equipment manufacturers who produce reliable and qualified equipment in Korea. We provide various equipment, such as syrup packaging line, eye-drop packaging line up to injectable packaging line, tube filling, pillow packaging machine, cartoning and so on.
Cannabis and Hemp contain CBD (Cannabidiol) and other cannabinoids. It has been shown to act as a 5-HT1A receptor agonist, an action which is involved in its antidepressant, anxiolytic and neuroprotective effects. Endoca has products on the market and developed technology to produce up to 99% pure cannabinoids from Hemp. We developed an industrial scale process for 99% pure CBD, CBG, CBN, and THC.
Enext is a company specialized in the design and construction of all kinds of installations for the pharmaceutical and biotech industry.
Enext was born in 2009 in Barcelona. From its very beginning, Enext relied on a qualified team with many years of experience in the pharmaceutical industry. For recent years, Enext has carried out about 30 turnkey projects including some new plants.
OUR VALUES Quality: Our philosophy is to carry out the projects with a high quality standard at a reasonable price.
Flexibility: For the last few years we have noticed that our medium-sized company profile and our way of working allows us to adapt better than our competitors to possible changes requested from our Clients in the middle of the project, which translates into shorter execution delays.
Commitment: Aware of the importance of their projects for our clients, our commitment focuses on:
Respecting the dates for the agreed deadlinesCarrying out the projects with the expected high quality which define usRespect the agreed prices
As one of the leading brand manufacturers in the OTC sector, Engelhard Arzneimittel primarily markets pharmacy-only over-the-counter medicines for self-medication. We research, develop and produce products for the treatment of respiratory tract diseases, skin conditions, digestive problems, and attention deficit disorders.
Enteco Pharma, a company founded in 1972, is today a market leader in Spain and Portugal. We are specialist in printing, cutting, lacquering and lamination of flexible primary packaging for the Pharmaceutical Industry with Certification ISO 9001, ISO 15378, clean rooms ISO 8 (Class 100.000) and DMF certification for aluminium and PVC/PVDC. Soon BRC, now in process. We have two production sites located in Mostoles (Madrid) and Navalmoral de la Mata (Caceres) and we can supply: aluminum blister with DMF certification, medical paper with lacquer, PVC, PVC/PVDC with DMF certification, PVC/PE/PVDC, PVC/PE for suppositories, coldforming, Alu + Pe (strips) and laminated and extruded material for sachets. At present, we have a customer portfolio of more than 140 clients in four continents. Products: Aluminium Blister Bivalent Lacquer, Aluminium PVDC Lacquer, PVC Blister, PVC + PVDC Blister, PVC/PE for suppositories, PVC + Polyethylene + PVDC, Aluminium + Polyethylene, Lamination and extrusion for sachets (Paper + Aluminium + Polyethylene, Polyester + Aluminium + Polyethylene, Paper + Polyethylene + aluminium + Heat Sealing Resin), Medical Grade Paper with Lacquer.
Envee Drugs Pvt. Ltd., ISO 9001-2008, WHO GMP certified API manufacturing units (Unit 1 – For Macrolide, Unit 2 – For Steroids, Unit 3 – API Intermediates) are located at strategic location from 1998. EDPL has evolved in Active pharma Ingredients & other pharmaceuticals formulations with world class expertise in development, manufacturing and supply of quality pharmaceutical products.
Our core products: Erythromycin & salts, Azithromycin, Clarithromycin, Roxithromycin, Betamethasone & Salts, Dexamethasone & Salts, Prednisolone & Salts
Enzybel is the reference for natural enzymes solutions. We develop Plant & Animal-derived enzymes and provide innovative solutions for the industry. Our enzymes are produced for Food & Beverages, Feed & Petfood, Pharma/Nutraceuticals & Technical, with a unique focus: high quality products with full traceability at competitive prices.
Enzychem Lifesciences Corporation is a Global New Drug Development Company that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center in Seoul and two GMP manufacturing plants in Seoul Korea, it has since been developing and producing APIs and functional health foods, and developing global new drugs. We produce an extensive array of curative products and cosmetic ingredients. Our flagship APIs include D-Cycloserine and Terizidone, Contrast Agent(MRI/CT), antibiotics in the family of cephalosporin such as Cefbuperazone, Cefazedone and other APIs for anti-coagulant and anti-inflammatory analgesic drugs.
Enzymaster is a Sino-Foreign Joint Venture company located in Ningbo City, one of the high-tech hubs in China's coastal areas, specialize in providing Enzyme Catalysis Solutions to the pharmaceutical and fine chemical industries, such as chiral intermediates. In March, 2018, our German subsidiary Enzymaster Deutschland GmbH established in Düsseldorf, mainly focus on the international business. We have established close collaboration with numerous pharmaceutical and fine chemical companies both in domestic and international market. We aim to facilitate the transformation of the chemical manufacturing processes towards environmentally friendly and cost effective processes.
The focus of Enzymicals is to provide integrated solutions for biocatalytic applications. Dedicated to design, develop and implement cost-effective, sustainable and scalable chemo-biocatalytic routes to APIs and intermediates, Enzymicals offers recognized expertise in the use of enzymatic processes for complex chemicals synthesis.
- The independent enterprise provides state of the art SOLUTIONS in development, optimization and piloting of robust chemo-enzymatic processes for the production of fine & specialty chemicals.
- The company manufactures a range of CHEMICALS as chiral building blocks, intermediates and specialty chemicals as well offer custom synthesis on request.
- Enzymicals offers a broad selection of recombinant ENZYMES suitable for research, development, production and diagnostics as well as a tailor-made protein expression and optimization service.
EPO Srl is an independent company established in 1933, producing high-quality botanical extracts. EPO can offer a great variety of products: dry, soft, fluid, tinctures, glycolic and liposoluble extracts, for pharmaceutical, nutraceutical, cosmetic, food and feed industries. The entire production process is set up and validated according to GMP regulations. EPO is also certified according to ISO 9001:2008, 21CFR111-GMP for dietary supplements, Kosher, BIOS (for organic products). Moreover, EPO was the first in Europe to launch a line of DNA certified extracts.
Erbozeta S.p.A., seated in the Republic of San Marino, has been
manufacturing dietary supplements and medical devices since 1987: we are now
present in about 50 countries in the world both with our branded products and
as contract manufacturer. We have a wide range of products, covering multiple therapeutic areas. We can also offer a complete contract manufacturing service
for food supplements, from the development of the formulation to the
preparation of the finished products ready for shipment.
The pharmaceutical division of ERCROS, S.A. manufactures Pharmaceutical Active Ingredients for the generic pharmaceutical market. Ercros pharmaceutical division has ISO, GMP and FDA ertificates. In its factory at Aranjuez (Madrid[Spain) produces by fermentation and by synthesis following products: Amlodipine besylate, Azithromycin, Clarithromycin, Erythromycins, Famotidine, Fosfomycins, Fosfomycin trometamol, Fusidic Acid, Sodium Fusidate and Terbinafine.
ERIOCHEM is an Argentinean pharmaceutical company focused on the synthesis of Active Pharmaceutical Ingredients (API), the manufacture of finished pharmaceutical products in the field of oncology and the development of added value generics or super-generics. Eriochem's plant was approved by authorities from the EMEA and the US-FDA, and for other regulatory agencies like South-Africa, Korea, Brazil, Belarus, etc. OXALIPLATIN: API and finished product, EU DCP procedure submitted. VINORELBINE: API and finished product, EU DCP procedure submitte. MELPHALAN FOR INJECTION: CTD dossier available for Q1 2009 GEMCITABINE FOR INJECTION: CTD dossier available for Q2 2009
Erregierre with its two production sites, one located in San Paolo D'Argon (Bergamo) and the other one located in Sovere (Bergamo), is a privately owned independent Italian company established in 1974. It is one of the leading manufacturer of pharmaceutical active ingredients produced by synthesis and exported worldwide. Erregierre has been FDA inspected and is strongly committed in manufacturing in strict accordance with cGMPs and at the highest international quality standards.
Esco Pharma is a leading manufacturer of containment and isolation systems with a global footprint spanning US, Europe and Asia. As a division of the Esco Group, Esco Pharma benefits from Esco's heritage in clean air and containment technologies dating back to 1978, in addition to the group's extensive global network of sales/services offices and manufacturing facilities. Esco Pharma also provides turnkey project services within the ASEAN region.
ESENSA is a company that produces dietary supplements, medical devices and general use products Including cosmetics and biocides.. It was founded in 2002 as a production department within FARMALOGIST, and as of 2007 has been operating under the name of ESENSA d.o.o. and is 100% privately owned. In 2009 ESENSA d.o.o obtained the permit to manufacture medical devices. In 2011 it acquired a permit to distribute pharmaceuticals, medicine and raw materials, as well as the permit to produce magisterial and galenic formulas in original packaging.
Our vision, mission and strategy are defined by assuring the quality of our product as well as good management. We see this as the true formula for attaining our goals as a company.
Esensa has certified quality management systems according to the requirements of ISO 9001:2008 with the certification body SGS, for the development and production of dietary supplements, medical devices and general purpose devices ISO 22000:2005, for the production of dietary supplements and ISO 13485:2003 FOR DEVELOPMENT, manufacturing and distribution of the nasal spray, ear spray, patches, ultrasound gel, intimate gels and sport injury sprays. Some of our products from the medical devices program, such as Marisol have received the CE mark and are exported to the EU market. Esensa has a HALAL certificate for 14 products from its range. As well, Esensa has obtained the certification of international regulations of EudraLex Volume IV EU Guidelines to Good Manufacturing Practice (GMP) in development and manufacturing of food supplements, medical devices and general use products.
Esensa's brand Marisol has received the prestigious award “Best of Serbia in 2011“.
ESIM Chemicals™ is a global leader in realizing visionary product development and manufacturing ideas in crop protection, flavor & fragrance, cosmetics, food & feed and other markets. As an established and flexible partner we are a trusted supplier of maleic anhydride, succinic anhydride, fumaric acid and its derivatives.
Eskag Pharma is a world-class manufacturer of Speciality
Generics at its WHO-GMP / ISO-9001:2008 certified Plants and offers plethora of
Nouvelle formulations like Diosmectite, Sucralfate Malate, Zinc Ascorbate, L
methylfolate, Enclomiphene Citrate, Calcium Lactate Gluconate, Ferrous Asparto
Glycinate, PEG in Liquid form (Laxative). Eskag addresses as many as ten
therapeutic areas in following categories:
*Contraceptives, Emergency Contraceptive Pills, Hormone Replacement Therapies
*Infertility management in Pre-ovulatory and ovulatory Phase
*Pre & Post-Menopausal Care
*Nutraceuticals and Probiotics Lozenges
*Chronic Kidney Diseases products like Phosphate binders and Dialysis Delayers
Full Dossiers and Regulatory Support available.
*Joint Ventures, Out licensing, Contract Manufacturing and Strategic partnerships.
Eskay Fine Chemicals, is part of SK group in India, doing business since 1932. We are a WHO GMP manufacturing company based in Mumbai. We manufacture Iodine, Barium and Selenium Compounds. Our main products are:- Barium Sulphate, Calcium Levulinate, Selenium Sulphide, Potassium Iodide, Sodium Iodide, Methyl Iodide, Trimethyl Sulphoxonium Iodide (TMSOI), Trimethyl Salyl Iodide (TMSI), Ammonium Iodide, Silver Iodide, Thymol Iodide, Iodoform, Diiodohydroxyquinoline (Iodoquinol), Iodochlorohydroxyquinoline (Clioquinol), Potassium Iodate, Sodium Iodate, Calcium Iodate, Potassium Metaper Iodate, Sodium Metaper Iodate, Diiodo Salisylic Acid (DISA).
For 50 years, we have been supplying complete packaging solutions and innovative ways to communicate important product information. Through our six production units we strive to offer maximum cost efficiency to our customers, regardless of your European location. We work together towards standardised processes throughout the value chain seeking constant optimisation and efficiency improvements.
Esparma Pharma Services GmbH, equipped with Europe modern plant technology, the core competencies lie in packing of solids, storage and picking of finished drugs.
Espee Group has been in the business of Pharmaceuticals since last 30
Group is currently involved in following activities,
- Contract Manufacturing and Distribution
- Formulation Exports
- Dossier Development (Semi Regulated/Regulated Market)
- Innovator Samples/Comparator/RLDs
- Generic Products Distribution
- Branded Nutraceutical Products Manufacturing and Distribution
Essentra supports customers globally with end-to-end healthcare packaging solutions. From primary and secondary packaging - cartons, leaflets, labels - to bespoke solutions for serialisation, patient adherence and tamper evidence, we work to your specifications. Combining a FTSE 250 company‘s global reach with local understanding, we help you solve packaging challenges.
ESSETI FARMACEUTICI is an Italian pharmaceutical company that from its beginning in 1956 has invested in the internationalization process anticipating times on competition, tracing new paths in the export of Italian production, a best banner in the world capable of transmitting and ensuring high quality standards and competitive prices in many markets. The products of our therapeutic areas combine top quality active ingredients made in Europe with innovative and excellence of the manufacturing process. The concept that characterizes the philosophy of our company is orientation to results, dynamism, innovation and attention to the international market.
EstechPharma Co., Ltd. manufactures and markets active pharmaceutical ingredients in South Korea. The company offers products under various categories, such as anti-inflammatory, analgesics, muscle relaxant, anti-septic, anti-spasmodics, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, and anti-histamine, as well as products for the treatment of alcoholism, urinary incontinence, etc.
ESTEVE is an integrated international group that pursues excellence in the pharmaceutical-chemical industry. Founded in 1929, our staff is around 2.900 people worldwide with a turnover around EURO 950 Million, headquartered in Barcelona (Spain).
API and Finished Dosage Form manufacturing sites are regularly inspected by US FDA.
ESTEVE's fields: NCE's, Generics, OTC, Animal Health, Vaccines, Home Respiratory Therapies and Dermatology.
We offer leading-edge capabilities in the development and manufacturing of complex formulations, mainly pellets and other solid oral forms, with customers on a world wide basis.
Esteve Química has 50 years' experience developing, manufacturing and marketing oral and injectable-non-sterile grade API's (generic and NCE's for third-parties) for regulated markets. Our services include process and analytical development, scale-up, analytical transfer, validation, process optimization and commercial manufacturing, along with any required technical services. We offer particle engineering posibilites (micronization, spray-drying ...). We are regularly inspected by major Health Authorities (USA, Europe, Japan ...). Our cGMP's multipurpose plants (two in Spain (EQ Esteve), one in Mexico (Sintenovo) and one in China (EHP) have a total capacity in exess of 800m3 and clean room areas for the last steps of manufacturing.
Esteve Huayi Pharmaceutical Co Ltd (EHP) is a joint venture between the Spanish Esteve Group and the Chinese Huadong Medicine Group.
Esteve Huayi Pharmaceutical Co Ltd is an industrial platform in China from which to supply the most demanding APIs markets (USA, EU, Japan) as well as the growing Chinese domestic market. It specializes in the development, manufacturing and commercialization of APIs and high-value added advanced intermediates as well as offering good opportunities for custom synthesis and toll manufacture projects using its state-of-the-art facilities with a wide range from cGMP-compliance kilo lab to commercial production, expertise in a variety of reaction types and a highly-qualified professional team
is a European-based specialty pharmaceutical company with global reach and a
committed player in the treatment of pain and addiction.
Ethypharm also develops and markets complex generics and essential medicines that help reduce healthcare costs, particularly in the field of emergency care and oncology.
The Company employs 1400 people mainly in Europe, and its drugs are marketed in more than 50 countries.
Our ambition is to become the European leader for the treatment of pain and addiction, and to help patients around the world gain access to high quality, essential and affordable medicines.
EUCODIS Bioscience is an application-driven enzyme engineering and manufacturing company. We engineer enzymes using our proprietary gene shuffling and in-vivo recombination toolbox, which enables effective modification of target enzymes. We provide customized services in strain, bioprocess and DSP development as well as recombinant protein and enzyme production up to industrial-scale (under ISO 9001). In addition we offer high-performance enzymes for specific applications in biopharma, fine chemicals, cosmetics and other industries: >50 enzymes including beta-lactamases, lipases, peroxidases, phospholipases D, nitrile hydratases and others, which are selected because of specific properties, like chiral and regioselectivity, broader temperature and pH-profiles, among others.
Eumedica Pharmaceuticals offers customised solutions across a comprehensive range of services: Regulatory Affairs & Pharmacovigilance; Distribution & Activation; On-demand Packaging; Tailored Logistics & Clinical Supplies. With more than 30 years' experience, we have become a key international player in the pharmaceutical industry and a pharma partner dedicated to the success of several multinational pharmaceutical companies. Eumedica Pharmaceuticals is an independent and international company that provides unique solutions and on-demand services to pharmaceutical companies, whatever their needs and location.
Eumedica Pharmaceuticals Industries is a company that is mainly devoted to the manufacturing of sterile APIs (sodium sulbactam, sulbactam+ ampicillin blend and disodium temocillin). Our expertise of more tan 30 years in the field and after having being audited and approved by the main Regulatory Authorities (FDA, AEMPS, PMDA, etc), we can be your first choice partner for your next project. Let's meet at the CPhI and discuss further details.
Eurofarma is among the largest pharmaceutical companies in Brazil. Present with its own operations in 19 countries in Latin America, Eurofarma is the first multinational pharmaceutical company from Brazil and counts on 6,000 employees in 11 manufacturing plants, producing around 260 million units (boxes) per year, providing high quality products at the right price. Internationalization is one of the main strategic goals of the company. Eurofarma has a strong plan to enlarge its portfolio in all countries around the world, by providing dossiers for registration and either out-licensing our brand or manufacturing finished products with the brand and layout of the client. Exports have spread to 18 countries across Latin America, Africa and Asia, focusing on high technology medicines such as oncologic drugs. Eurofarma has built more than 40 years of history providing access to health and quality of life, sharing its value with employees and society.